A long-term cannabis user, looking back across two decades of daily consumption that began at thirteen, offers what science is only now learning to say plainly: that legalization and safety are not the same thing, and that the adolescent brain — still forming its architecture for mood, memory, and impulse — is uniquely vulnerable to lasting harm. The accumulation of research on psychiatric risk and neural change has outpaced the cultural messaging that followed legalization, leaving a generation of young people navigating a substance whose legal status has quietly come to imply a safety it doe
Long-term cannabis user reflects on adolescent risks of early marijuana use
Related Coverage
Dozens of UK homebuyers report serious defects in new-build properties including mould, structural issues, and damp. Com…
The Guardian · Sep 04 New Zealand becomes second nation to approve MDMA for severe PTSD treatmentNew Zealand's Medsafe approved two psychiatrists to prescribe pharmaceutical-grade MDMA for severe PTSD, making it only …
Insurance Business · Sep 04 Intact Insurance Defeats Chronic Pain Claim Under Ontario's Minor Injury CapA Licence Appeal Tribunal rejected a claimant's attempt to exceed Ontario's $3,500 minor injury cap following a 2023 car…
News-Medical · Sep 04 Study identifies how prednisone impairs bone health in children with muscular dystrophyResearch identifies blood proteins explaining how prednisone, while treating Duchenne muscular dystrophy, impairs childh…
Bias & Framing
No detailed analysis data available for this lens. Try re-running lenses from the admin panel.
Geopolitical Impact
This article addresses public health concerns about adolescent cannabis use, not geopolitical matters.
Economic Lens
Personal accounts and research highlight mental health risks from adolescent cannabis use, potentially influencing public health policy and legal cannabis market regulation.
Consumers, particularly parents and adolescents, may face increased healthcare costs for mental health treatment; potential demand for mental health services and psychiatric care may rise; consumers may reduce cannabis purchases due to health concerns.
Likely increased regulatory scrutiny on cannabis marketing to youth, potential age-restriction enforcement, possible requirements for health warnings, increased funding for mental health research and adolescent addiction treatment programs, and potential restrictions on product potency or accessibility.